The U.S. will use smaller doses of the monkeypox vaccine in order to stretch its supply.
RELATED: Pfizer launches Lyme disease vaccine trial
Monkeypox vaccine shots will soon be delivered differently and in a way that allows 5 doses to be obtained from a current single dose.
The Food and Drug Administration Tuesday issued an emergency use authorization for the Jynneos monkeypox vaccine so it can be available for adults as a so-called intradermal injection, which penetrates only the top layer of skin.
In a Tuesday afternoon call with news media, members of the Biden Administration urged state and local officials who still have doses of Jynneos available to immediately switch to intradermal injections to conserve vaccines.
The federal government has purchased and already allocated more than 600,000 Jynneos doses. States and localities can order additional vaccine once they have used 90% of the stock allocated to them.
» Subscribe to USA TODAY:
» Watch more on this and other topics from USA TODAY:
» USA TODAY delivers current local and national news, sports, entertainment, finance, technology, and more through award-winning journalism, photos, videos and VR.
#monkeypox #fda #vaccines
These two are a good case for green screens.😅
“Schlong covid” 😂
The USSA
Lol😂
🤪🤪🤪